XML 14 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 4,035 $ 14,206
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 10,308 8,953
Amortization of premiums, discounts and issuance costs 200 393
Stock-based compensation expense 3,067 3,009
Deferred income taxes 686 2,008
Other (1,265) (391)
Changes in assets and liabilities:    
Accounts receivable (9,936) 21,345
Prepaid expenses and other current assets 3,756 (4,470)
Other long-term assets 5,900 952
Accounts payable and accrued expenses (141,463) (150,125)
Income taxes payable 3,017 5,299
Long-term professional liabilities 4,082 2,378
Other liabilities (5,011) (4,201)
Net cash used in operating activities - continuing operations (122,624) (100,644)
Net cash used in operating activities - discontinued operations (2,602) (273)
Net cash used in operating activities (125,226) (100,917)
Cash flows from investing activities:    
Acquisition payments, net of cash acquired (8,167) (1,667)
Purchases of investments (16,896) (9,549)
Proceeds from maturities or sales of investments 14,155 6,865
Purchases of property and equipment (5,330) (6,999)
Net cash used in investing activities (16,238) (11,350)
Cash flows from financing activities:    
Borrowings on line of credit 170,500 216,000
Payments on line of credit (90,500) (106,000)
Payments on term loan (3,125) (3,125)
Payment on finance lease obligation (690) (703)
Proceeds from issuance of common stock 860 1,095
Repurchases of common stock (887) (775)
Other 46 2,075
Net cash provided by financing activities 76,204 108,567
Net decrease in cash and cash equivalents (65,260) (3,700)
Cash and cash equivalents at beginning of period 73,258 9,824
Cash and cash equivalents at end of period $ 7,998 $ 6,124